Literature DB >> 17521312

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity.

E Nizankowska-Mogilnicka1, G Bochenek, L Mastalerz, M Swierczyńska, C Picado, G Scadding, M L Kowalski, M Setkowicz, J Ring, K Brockow, C Bachert, S Wöhrl, B Dahlén, A Szczeklik.   

Abstract

Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most common causes of adverse drug reactions. Majority of them are of the hypersensitivity type. The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/angioedema (AIU). The decisive diagnosis is based on provocation tests with aspirin, as the in vitro test does not hold diagnostic value as yet. Detailed protocols of oral, bronchial and nasal aspirin provocation tests are presented. Indications, contraindications for the tests, the rules of drug withdrawal and equipment are reviewed. Patient supervision and interpretations of the tests are proposed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521312     DOI: 10.1111/j.1398-9995.2007.01409.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  76 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  Diagnostic tools in Rhinology EAACI position paper.

Authors:  Glenis Scadding; Peter Hellings; Isam Alobid; Claus Bachert; Wytske Fokkens; Roy Gerth van Wijk; Philippe Gevaert; Josep Guilemany; Livije Kalogjera; Valerie Lund; Joaquim Mullol; Giovanni Passalacqua; Elina Toskala; Cornelius van Drunen
Journal:  Clin Transl Allergy       Date:  2011-06-10       Impact factor: 5.871

Review 3.  [Aspirin-Intolerance-Syndrom : a common and interdisciplinary disease].

Authors:  C Umbreit; J C Virchow; C Thorn; K Hörmann; L Klimek; O Pfaar
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

Review 4.  Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).

Authors:  Ronald A Simon; Kristen M Dazy; Jeremy D Waldram
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

5.  [Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].

Authors:  U Förster-Ruhrmann; W Behrbohm; G Pierchalla; A J Szczepek; J W Fluhr; H Olze
Journal:  HNO       Date:  2019-08       Impact factor: 1.284

6.  [The NTP in allergy research : open questions regarding nasal provocation tests using allergens].

Authors:  U Förster; A Sperl; L Klimek
Journal:  HNO       Date:  2013-10       Impact factor: 1.284

Review 7.  Peri-operative anaphylaxis.

Authors:  Linda Nel; Efrem Eren
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

8.  Association analysis of member RAS oncogene family gene polymorphisms with aspirin intolerance in asthmatic patients.

Authors:  Jong-Sook Park; Jeong-Seok Heo; Hun Soo Chang; Inseon S Choi; Mi-Kyeong Kim; Jong-Uk Lee; Byung Lae Park; Hyoung Doo Shin; Choon-Sik Park
Journal:  DNA Cell Biol       Date:  2014-02-20       Impact factor: 3.311

9.  Nonsteroidal anti-inflammatory drug administration in children with history of wheeze.

Authors:  Kendra Sih; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-08       Impact factor: 3.275

10.  Update on the management of antibiotic allergy.

Authors:  Bernard Yu-Hor Thong
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.